Ascending cholangitis natural history, complications and prognosis

Jump to navigation Jump to search

Ascending cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Ascending cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ascending cholangitis natural history, complications and prognosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ascending cholangitis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ascending cholangitis natural history, complications and prognosis

CDC on Ascending cholangitis natural history, complications and prognosis

Ascending cholangitis natural history, complications and prognosis in the news

Blogs on Ascending cholangitis natural history, complications and prognosis

Directions to Hospitals Treating Ascending cholangitis

Risk calculators and risk factors for Ascending cholangitis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anila Hussain, MD [2]

Overview

The severity of ascending cholangitis can range anywhere from mild to life-threatening and can be fatal if left untreated. Complications of acute cholangitis may include sepsis, hepatic abscesses, liver failure, renal failure, pancreatitis as well as postoperative complications like pneumonia, respiratory failure, heart failure, cardiac arrhythmias, cardiac ischemia, gastrointestinal bleeding, bile leaking into peritoneum or abdomen, renal abscess, fistulae, wound infection, wound dehiscence and disseminated intravascular coagulation (DIC)[1]. Acute cholangitis bears a significant risk of death, with the leading cause being irreversible shock with multiple organ failure (which could have multiple possible complications of severe infections). Modern improvements in diagnosis and treatment have led to a reduction in mortality. Prognosis is good in patients who have quick and adequate drainage where there is an improvement in hemodynamic and inflammatory parameters. Prognosis of the disease depends on the severity of the illness. Poor outcomes are seen if urgent surgery is required for drainage

Natural History

Ascending Cholangitis, also known as acute cholangitis is a systemic disease caused by the inflammation and infection of the biliary tree most commonly following an obstruction in the biliary tract. It is characterized by a triad (Charcot's Triad) of fever, jaundice and right upper quadrant pain. A pentad (also known as Reynold's pentad) can also be seen in which altered mental status and sepsis are present in addition to usual findings. The severity of disease range anywhere from mild infection to life-threatening sepsis by the translocation of bacteria into the bloodstream[2]. If left untreated, patients with ascending cholangitis may progress to develop severe sepsis and multiorgan failure leading to death[3]

Complications

Some complications of ascending cholangitis include;

Other complications that are seen in ascending cholangitis patients can occur following the treatment. Post-operative complications may include:[4]

Prognosis

  • Acute cholangitis bears a significant risk of death, with the leading cause being irreversible shock with multiple organ failure (which could have multiple possible complications of severe infections). Modern improvements in diagnosis and treatment have led to a reduction in mortality.
  • Before 1980, the mortality rate was greater than 50%; However, in the past thirty years, it has decreased to 10-30%[5].[6]. Mortality rate after the year 2000 was found to be 2700-10,000 per 100,000[7]. These differences in mortality can likely be attributed to improvements in early diagnosis and supportive treatment.
  • Patients with signs of multiple organ failure have a high mortality risk and need urgent biliary drainage and treatment with systemic antibiotics. Other causes of death following severe cholangitis include heart failure and pneumonia.

Prognosis of disease depends on the severity of the illness. Poor outcomes are seen if urgent surgery is required for drainage. Severe ascending cholangitis is associated with organ dysfunction in one or more organ as described below:[8]

  • Hypotension requiring dopamine ≥5 μg/kg per min, or any dose of nor-epinephrine
  • Altered mental status or disturbance of consciousness
  • Respiratory compromise - PaO2/FiO2 ratio <300
  • Renal dysfunction - Oliguria and serum creatinine >2.0 mg/dl
  • Hepatic abnormalities with PT‐INR >1.5
  • Hematological dysfunction - Platelet count <100,000/mm3

Other bad prognostic factor in addition to organ dysfunction include preexisting cirrhosis, hypoalbuminemia[9], bilirubin > 90umol/L, thrombocytopenia, female sex and old age.[10]

References

  1. Lai EC, Tam PC, Paterson IA, Ng MM, Fan ST, Choi TK; et al. (1990). "Emergency surgery for severe acute cholangitis. The high-risk patients". Ann Surg. 211 (1): 55–9. PMC 1357893. PMID 2294844.
  2. Boey JH, Way LW (1980). "Acute cholangitis". Ann Surg. 191 (3): 264–70. PMC 1344694. PMID 7362292.
  3. Muir CA (2004). "Acute ascending cholangitis". Clin J Oncol Nurs. 8 (2): 157–60. doi:10.1188/04.CJON.157-160. PMID 15108417.
  4. Lai EC, Tam PC, Paterson IA, Ng MM, Fan ST, Choi TK; et al. (1990). "Emergency surgery for severe acute cholangitis. The high-risk patients". Ann Surg. 211 (1): 55–9. PMC 1357893. PMID 2294844.
  5. Thompson JE, Pitt HA, Doty JE, Coleman J, Irving C (1990). "Broad spectrum penicillin as an adequate therapy for acute cholangitis". Surg Gynecol Obstet. 171 (4): 275–82. PMID 2218831.
  6. Salek J, Livote E, Sideridis K, Bank S (2009). "Analysis of risk factors predictive of early mortality and urgent ERCP in acute cholangitis". J Clin Gastroenterol. 43 (2): 171–5. doi:10.1097/MCG.0b013e318157c62c. PMID 18769362.
  7. Kimura Y, Takada T, Strasberg SM, Pitt HA, Gouma DJ, Garden OJ; et al. (2013). "TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis". J Hepatobiliary Pancreat Sci. 20 (1): 8–23. doi:10.1007/s00534-012-0564-0. PMID 23307004.
  8. Kiriyama, Seiki; Takada, Tadahiro; Strasberg, Steven M.; Solomkin, Joseph S.; Mayumi, Toshihiko; Pitt, Henry A.; Gouma, Dirk J.; Garden, O. James; Büchler, Markus W.; Yokoe, Masamichi; Kimura, Yasutoshi; Tsuyuguchi, Toshio; Itoi, Takao; Yoshida, Masahiro; Miura, Fumihiko; Yamashita, Yuichi; Okamoto, Kohji; Gabata, Toshifumi; Hata, Jiro; Higuchi, Ryota; Windsor, John A.; Bornman, Philippus C.; Fan, Sheung-Tat; Singh, Harijt; de Santibanes, Eduardo; Gomi, Harumi; Kusachi, Shinya; Murata, Atsuhiko; Chen, Xiao-Ping; Jagannath, Palepu; Lee, Sung Gyu; Padbury, Robert; Chen, Miin-Fu; Dervenis, Christos; Chan, Angus C.W.; Supe, Avinash N.; Liau, Kui-Hin; Kim, Myung-Hwan; Kim, Sun-Whe (2013). "TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos)". Journal of Hepato-Biliary-Pancreatic Sciences. 20 (1): 24–34. doi:10.1007/s00534-012-0561-3. ISSN 1868-6974.
  9. Tsuyuguchi, Toshio; Sugiyama, Harutoshi; Sakai, Yuji; Nishikawa, Takao; Yokosuka, Osamu; Mayumi, Toshihiko; Kiriyama, Seiki; Yokoe, Masamichi; Takada, Tadahiro (2012). "Prognostic factors of acute cholangitis in cases managed using the Tokyo Guidelines". Journal of Hepato-Biliary-Pancreatic Sciences. 19 (5): 557–565. doi:10.1007/s00534-012-0538-2. ISSN 1868-6974.
  10. Liu CL, Fan ST. Acute cholangitis. In: Holzheimer RG, Mannick JA, editors. Surgical Treatment: Evidence-Based and Problem-Oriented. Munich: Zuckschwerdt; 2001. Available from: https://www.ncbi.nlm.nih.gov/books/NBK6921/

Template:WikiDoc Sources